Cargando…
Cancer Vaccines, Treatment of the Future: With Emphasis on HER2-Positive Breast Cancer
Breast cancer is one of the leading causes of death in women. With improvements in early-stage diagnosis and targeted therapies, there has been an improvement in the overall survival rate in breast cancer over the past decade. Despite the development of targeted therapies, tyrosine kinase inhibitors...
Autores principales: | Pallerla, Sandeep, Abdul, Ata ur Rahman Mohammed, Comeau, Jill, Jois, Seetharama |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828795/ https://www.ncbi.nlm.nih.gov/pubmed/33466691 http://dx.doi.org/10.3390/ijms22020779 |
Ejemplares similares
-
Proximity ligation assay to study protein–protein interactions of proteins on two different cells
por: Sable, Rushikesh, et al.
Publicado: (2018) -
A peptidomimetic with a chiral switch is an inhibitor of epidermal growth factor receptor heterodimerization
por: Kanthala, Shanthi P., et al.
Publicado: (2017) -
Lipidated Peptidomimetic Ligand-Functionalized HER2 Targeted Liposome as Nano-Carrier Designed for Doxorubicin Delivery in Cancer Therapy
por: Naik, Himgauri, et al.
Publicado: (2021) -
Targeting HER2-positive breast cancer: advances and future directions
por: Swain, Sandra M., et al.
Publicado: (2022) -
Surfing the Protein-Protein Interaction Surface Using Docking Methods: Application to the Design of PPI Inhibitors
por: Sable, Rushikesh, et al.
Publicado: (2015)